Inflammatory bowel disease linked to prostate cancer

December 7, 2018, Northwestern University
Micrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia

Men with inflammatory bowel disease have four to five times higher risk of being diagnosed with prostate cancer, reports a 20-year study from Northwestern Medicine.

This is the first report to show men with inflammatory bowel disease have higher than average PSA () values, and this group also has a significantly higher risk of potentially dangerous prostate cancer.

About 1 million men have inflammatory bowel disease in the U.S. Inflammatory bowel disease is a common chronic condition that includes Crohn's disease and .

"These patients may need to be screened more carefully than a man without inflammatory bowel disease," said lead study author Dr. Shilajit Kundu. "If a man with inflammatory bowel disease has an elevated PSA, it may be an indicator of prostate cancer."

Kundu is an associate professor of urology at Northwestern University Feinberg School of Medicine and a Northwestern Medicine physician. He also is a member of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University.

The study was published in European Urology this week.

In his practice, Kundu sees many men with inflammatory bowel disease who have elevated PSA tests.

"Many doctors think their PSA is elevated just because they have an inflammatory condition," Kundu said. "There is no data to guide how we should treat these men."

For the extensive study, researchers looked at 1,033 men with inflammatory bowel disease and a of 9,306 men without the disease. They followed the two groups of men for 18 years and found those with were much more likely to have prostate cancer and higher PSA levels.

Northwestern scientists are now working to understand the mechanism of how gut inflammation leads to .

Explore further: Psoriasis linked to increased risk for inflammatory bowel disease

More information: Jacob A. Burns et al, Inflammatory Bowel Disease and the Risk of Prostate Cancer, European Urology (2018). DOI: 10.1016/j.eururo.2018.11.039

Related Stories

Psoriasis linked to increased risk for inflammatory bowel disease

October 30, 2018
(HealthDay)—Psoriasis appears to be significantly associated with inflammatory bowel disease (IBD), according to a review published online Oct. 24 in JAMA Dermatology.

Inflammatory bowel disease in childhood associated with increased risk of cancer

September 21, 2017
Children who develop inflammatory bowel disease (ulcerative colitis or Crohn's disease) run a higher risk of cancer, both in childhood and later in life, a study from Karolinska Institutet published in the BMJ reports.

Increased mortality in children with inflammatory bowel disease

October 19, 2018
Children who develop inflammatory bowel disease (ulcerative colitis or Crohn's disease) have an increased risk of death, both in childhood and later in life, a study from Karolinska Institutet published in the journal Gastroenterology ...

Oxysterols guide gut immune cells and are involved in inflammatory bowel disease

January 16, 2018
Researchers at Karolinska Institutet in Sweden report that cholesterol metabolites cause specific immune cells in the large intestine to move, which lies behind the formation of the immune system's important lymphoid tissue ...

Analysis challenges link between pain medications and inflammatory bowel disease

April 5, 2018
Contrary to generally accepted belief, a recent review and analysis of published studies did not reveal a consistent association between the use of nonsteroidal anti-inflammatory drugs (NSAIDs) or acetaminophen and exacerbation ...

Older people with bowel disease receive older medicines

November 13, 2017
Inflammatory bowel disease is common amongst older people and there are big differences in the choice of treatment for different age groups. Patients over the age of 60 often receive cortisone drugs instead of more modern ...

Recommended for you

Potential seen for tailoring treatment for acute myeloid leukemia

December 8, 2018
Advances in rapid screening of leukemia cells for drug susceptibility and resistance are bringing scientists closer to patient-tailored treatment for acute myeloid leukemia (AML).

Study may offer doctors a more effective way to treat neuroblastoma

December 7, 2018
A very large team of researchers, mostly from multiple institutions across Germany, has found what might be a better way to treat patients with neuroblastoma, a type of cancer. In their paper published in the journal Science, ...

Inflammatory bowel disease linked to prostate cancer

December 7, 2018
Men with inflammatory bowel disease have four to five times higher risk of being diagnosed with prostate cancer, reports a 20-year study from Northwestern Medicine.

'Chemo brain' caused by malfunction in three types of brain cells, study finds

December 6, 2018
More than half of cancer survivors suffer from cognitive impairment from chemotherapy that lingers for months or years after the cancer is gone. In a new study explaining the cellular mechanisms behind this condition, scientists ...

Scientists develop new technology for profiling unique genetic makeup of myeloma tumor cells

December 6, 2018
Cancer arises when cells lose control. Deciphering the "blueprint" of cancer cells—outlining how cancer cells hijack specific pathways for uncontrolled proliferation—will lead to more efficient ways to fight it. Joint ...

Putting the brakes on tumor stealth

December 6, 2018
New research undertaken at Monash University has shed new light on how some cancers are able to escape our immune system.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.